Impact of Canola Protein Processing on Plasma Amino Acid Responses
CANOLAA
The Impact of Canola Protein Processing on Postprandial Plasma Amino Acid Responses in Vivo in Young Females
1 other identifier
interventional
15
1 country
1
Brief Summary
Muscle tissue consists of proteins. These proteins are built up of small building blocks: amino acids. By consuming enough protein through the diet, the body is provided with enough amino acids to facilitate muscle protein building. Providing the growing world population with sufficient animal-derived protein is a challenge. Plant proteins can be produced on a more sustainable commercial scale than conventional animal-derived proteins and therefore can contribute to feeding our future population. Canola protein is a protein that is derived from rapeseed. The composition of canola seems to be comparable to that of other high-quality animal based protein sources. However, the collection of canola protein from rapeseed occurs in a special way. These treatment processes might affect canola protein digestion. The goal of this study is to investigate the most optimal way of canola protein processing on blood plasma amino acid responses. Primary objective: To assess the impact of canola protein processing on 5h postprandial plasma total amino acid incremental area under the curve (iAUC) in vivo in healthy young females. Hypothesis: it is hypothesized that the ingestion of 20g processed canola will result in greater 5h postprandial plasma total amino acid iAUC in vivo in healthy young females, when compared to the ingestion of 20g native canola protein isolate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedStudy Start
First participant enrolled
October 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 27, 2024
CompletedMarch 30, 2026
October 1, 2023
8 months
September 5, 2023
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total amino acid availability
The total amino acid availability is expressed as the incremental area under the curve (iAUC)
0 - 5 hours after drink ingestion
Secondary Outcomes (7)
Postprandial plasma total amino acid concentrations
0 - 5 hours after drink ingestion
Postprandial plasma individual amino acid concentrations
0 - 5 hours after drink ingestion
Peak plasma amino acid concentrations
0 - 5 hours after drink ingestion
Time to peak plasma amino acid concentrations
0 - 5 hours after drink ingestion
iAUC essential amino acids concentrations
0 - 5 hours after drink ingestion
- +2 more secondary outcomes
Other Outcomes (12)
Age in years
Baseline at screening
Bodymass in kg
Baseline at screening
Height in m
Baseline at screening
- +9 more other outcomes
Study Arms (4)
Native canola protein
EXPERIMENTAL20g of canola protein
Processed canola protein #1
EXPERIMENTAL20g of processed canola #1
Processed canola protein #2
EXPERIMENTAL20g of processed canola #2
Whey protein
ACTIVE COMPARATOR20g of whey protein
Interventions
Ingestion of a 300 mL drink containing 20g whey protein
Ingestion of a 300 mL drink containing 20g native canola protein
Ingestion of a 300 mL drink containing 20g processed canola protein #1
Ingestion of a 300 mL drink containing 20g processed canola protein #2
Eligibility Criteria
You may qualify if:
- Female sex
- Aged between 18 and 35 y inclusive
- BMI between 18.5 and 30 kg/m2
You may not qualify if:
- Intolerant to milk lactose
- Allergic to milk protein / products
- Mustard allergy
- Vegan lifestyle
- Participating in a structured (progressive) exercise program
- Smoking regularly
- Diagnosed GI tract disorders or diseases
- Diagnosed musculoskeletal disorders
- Diagnosed metabolic disorders (e.g., diabetes)
- Hypertension (blood pressure above 140/90 mmHg)
- Donated blood 2 months prior to test day
- Pregnant
- Using third generation oral contraceptives
- Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories).
- Chronic use of gastric acid suppressing medication as this impairs protein digestion (i.e., proton pump inhibitors, H2-antagonists)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- DSM Food Specialtiescollaborator
Study Sites (1)
Maastricht University Medical Centre+
Maastricht, Limburg, 6229ER, Netherlands
Related Publications (1)
Boot N, Hermans WJH, Warnke I, Overman A, van Kranenburg JMX, Senden JM, Verdijk LB, van Loon LJC. Evaluation of processing of canola protein isolate on postprandial plasma amino acid profiles in healthy, young females. Amino Acids. 2025 Oct 17;57(1):50. doi: 10.1007/s00726-025-03482-1.
PMID: 41107640DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luc van Loon, PhD
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2023
First Posted
September 28, 2023
Study Start
October 3, 2023
Primary Completion
May 27, 2024
Study Completion
May 27, 2024
Last Updated
March 30, 2026
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share